ARCHIVES

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

This article is from The Cancer Letter archive.

Vol. 33 No. 16 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

ODAC Votes for Marqibo Accelerated Approval

March 30, 2012

UICC Congress Urges World Commitment To Cancer Prevention.

July 14, 2006

Public Should Be Warned About Smokeless tobacco Risks, Panel Says

January 24, 1986

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

October 9, 1987

Over $20 Million Carved Out From Statistical, Operations Centers

May 16, 2014

In Brief: Schweiler Resigns, President Appoints Former Massachusetts Congresswoman Margaret Heckler

January 21, 1983